Interestingly, reduced VPS35 levels predispose patients to Alzheimer’s pathology [68], and pharmacological chaperones that stabilize the retromer complex promote its function in APP trafficking [69], suggesting that similar approaches may be beneficial in PD. This evidence concerns the gene VPS35 and Parkinson disease.